CAS 3607-34-9

(E)-Doxepin-d6

CAS : 3607-34-9

Formule : C₁₉H₁₅D₆NO

Masse moléculaire : 285.42

Ref: 4Z-D-1518

(E)-Doxepin-d3

Produit contrôlé

CAS : 3607-34-9

(E)-Doxepin-d3 is an inhibitor of human tumor kinases and has been shown to have anticancer properties. It is a deuterated analog of (E)-doxepin, which is a potent inhibitor of protein kinases. (E)-Doxepin-d3 has been found to inhibit the growth and proliferation of cancer cells in vitro and in vivo. It induces apoptosis, or programmed cell death, in Chinese hamster ovary cells and human leukemia cells through the activation of caspase-3. Astaxanthin, another protein kinase inhibitor, has been used in combination with (E)-doxepin-d3 to enhance its anticancer effects. In addition, (E)-doxepin-d3 has been detected in urine samples from cancer patients undergoing treatment with this drug.

Formule : C₁₉H₂₁NO

Degré de pureté : Min. 95%

Masse moléculaire : 279.4 g/mol

Ref: 3D-DAA60734